0.24 (-%)
As of Oct 30, 2024
Source:
SciSparc’s proprietary compounds capitalize on the biochemistry of receptors that specialize in modulating the central nervous system to create therapeutics that mitigate the adverse symptoms associated with CNS disorders.
| Country | Israel |
| Headquarters | tel aviv |
| Phone Number | 972-3-6103100 |
| Industry | manufacturing |
| CEO | Oz Adler |
| Website | scisparc.com |